This MRes offers specialised training with exposure to research scientists and members of the pharmaceutical industry. It provides a foundation year for a research career in drug development and a comprehensive programme in research methodology. Students will undertake a significant research project during this MRes.
Students develop practical understanding of research methods in biomedical science and knowledge of cutting-edge research techniques alongside practical experience in laboratory, clinical or epidemiological research. They develop the ability to evaluate scientific literature and gain an appreciation of ethical and governance requirements of research, including 'Good Clinical Practice' principles.
Students undertake modules to the value of 180 credits.
The programme consists of four core taught modules (75 credits) and a research dissertation (105 credits).
A Postgraduate Diploma (120 credits) is offered.
There are no optional modules for this programme.
All MRes students undertake an independent research project which culminates in a dissertation of 15,000 words.
Teaching and learning
The programme is delivered through a combination of lectures, practicals, small group seminars and laboratory work. Assessment is through presentations, essays, examination and the research dissertation.
Further information on modules and degree structure is available on the department website: Clinical Drug Development MRes
Graduates of the programme have used the qualification to pursue careers in the pharmaceutical industry and medicine, while a significant proportion of students go on to study for PhD degrees at UCL and other institutions worldwide.
Recent career destinations for this degree
This programme runs within the School of Life and Medical Sciences, one of the most highly rated medical research organisations in the UK. Close links with clinical colleagues in the UCL group of hospitals provides cutting-edge medical expertise and links to world-leading clinical research.
Careers data is taken from the ‘Destinations of Leavers from Higher Education’ survey undertaken by HESA looking at the destinations of UK and EU students in the 2013–2015 graduating cohorts six months after graduation.
The Division of Medicine has as its mission the performance of innovative, high-quality biomedical research and excellence in graduate training.
This MRes programme provides an opportunity for students to develop theoretical knowledge, understanding and practical skills in research methodology. These include statistical methods applied to medical research and drug development in a specific biomedical area.
Over the course of the year, students will have the opportunity to build a network of contacts from both academia and industry, increasing their future career prospects.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Division of Medicine
80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
Visit the Clinical Drug Development (MRes/PGDip) page on the University College London website for more details!